Ophthalmologic manifestations commonly misdiagnosed as demyelinating events in multiple sclerosis patients.
- Published in:
- 2011
- Publication type:
- Opinion
Works matching IS 20412177 AND DT 2011 AND VI 3 AND IP 1
Results: 35
1
2
Neurocognitive sequelae in African American and Caucasian children with multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
3
Causes of death among patients with multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
4
Incidental MRI lesions suggestive of multiple sclerosis in asyrnptomatic patients in Karachi, Pakistan.
- Published in:
- 2011
- Publication type:
- Opinion
5
Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
6
Characterization of brain lesions in a mouse model of progressive multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
7
12 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
8
Relapsing demyelinating CNS disease in a Korean pediatric population: multiple sclerosis versus neuromyelitis optica.
- Published in:
- 2011
- Publication type:
- Opinion
9
Spinal cord ring enhancement in multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
10
Tubulin polymerization promoting protein (TPPP/p25) as a marker for oligo- dendroglial changes in multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
11
Temporal pattern of ICAM-l mediated regulatory T cell recruitment to sites of inflammation adoptive transfer model of multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
12
Regulatory T cells exhibit enhanced migratory characteristics, a feature impaired in patients with multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
13
Distinct properties of circulating CD8<sup>+</sup> cells in FTV720-treated patients with multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
14
Assessing changes in relapse rates in multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
15
Safety and I cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
16
The potential role of B cell-targeted therapies in multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
17
No evidence of JC virus reactivation in natalizumab treated multiple sclerosis patients: an 1 8 month follow-up study.
- Published in:
- 2011
- Publication type:
- Opinion
18
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
19
Teriflunomide, an inhibitor of dihydroorotate dehydrogenase for the potential oral treatment of multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
20
Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
21
A method for evaluating treatment switching criteria in multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
22
Intrathecal methotrexate treatment in multiple sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2011, v. 3, n. 1, p. 17
- Publication type:
- Article
23
Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment.
- Published in:
- 2011
- Publication type:
- Opinion
24
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.
- Published in:
- 2011
- Publication type:
- Opinion
25
Mitoxantrone for worsening multiple sclerosis: tolerability, toxicity, adherence and efficacy in the clinical setting.
- Published in:
- 2011
- Publication type:
- Opinion
26
Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses.
- Published in:
- 2011
- Publication type:
- Opinion
27
Neuromyelitis optica associated with subacute human T-lymphotropic virus type 1 infection.
- Published in:
- 2011
- Publication type:
- Opinion
28
Absence of cortical demyelination in neuromyelitis optica.
- Published in:
- 2011
- Publication type:
- Opinion
29
Neuromyelitis optica and NMO-IgG in European pediatric patients.
- Published in:
- 2011
- Publication type:
- Opinion
30
Proton MRS of large multiple sclerosis lesions reveals subtle changes in metabolite 1(1) and area.
- Published in:
- 2011
- Publication type:
- Opinion
31
Heterogeneous pattern of retinal nerve fiber layer in multiple sclerosis. High resolution optical coherence tomography: potential and limitations.
- Published in:
- 2011
- Publication type:
- Opinion
32
Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
33
The contribution of MRI in assessing cognitive impairment in multiple sclerosis.
- Published in:
- 2011
- Publication type:
- Opinion
34
Early Treatment of Multiple Sclerosis.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2011, v. 3, n. 1, p. 1
- By:
- Publication type:
- Article
35
Foreword.
- Published in:
- Current Medical Literature: Multiple Sclerosis, 2011, v. 3, n. 1, p. 1
- By:
- Publication type:
- Article